Definium Therapeutics's total assets for Q1 2026 were $401.29M, a decrease of -8.82% from the previous quarter. DFTX total liabilities were $122.44M for the fiscal quarter, a 13.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.